These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 1506634)

  • 1. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
    Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
    J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
    Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
    Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial damage caused by the semisynthetic penicillins cloxacillin dicloxacillin and flucloxacillin].
    Sinapius D; Bründel KH
    Vasa; 1975; 4(1):54-8. PubMed ID: 1189592
    [No Abstract]   [Full Text] [Related]  

  • 4. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.
    Boyd IW
    Med J Aust; 1999 Aug; 171(4):219. PubMed ID: 10494242
    [No Abstract]   [Full Text] [Related]  

  • 6. Flucloxacillin and cholestatic hepatitis.
    Jick H; Derby LE; Dean AD; Henry DA
    Med J Aust; 1994 Apr; 160(8):525. PubMed ID: 8170433
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicities of flucloxacillin and dicloxacillin--is there really a difference?
    Gosbell IB; Turnidge JD; Tapsall JW; Benn RA
    Med J Aust; 2000 Nov; 173(9):500-1. PubMed ID: 11149309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk of liver reactions after treatment with flucloxacillin].
    Lakartidningen; 1989 Mar; 86(11):977-8. PubMed ID: 2927200
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between penicillinase production and the in-vitro activity of methicillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, and cephalothin against strains of Staphylococcus aureus of different phage patterns and penicillinase activity.
    Frimodt-Møller N; Rosdahl VT; Sørensen G; Hartzen SH; Bentzon MW
    J Antimicrob Chemother; 1986 Jul; 18(1):27-33. PubMed ID: 3489704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.
    Russmann S; Kaye JA; Jick SS; Jick H
    Br J Clin Pharmacol; 2005 Jul; 60(1):76-82. PubMed ID: 15963097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
    Rodriguez-Solares A; Pérez-Gutiérrez F; Prosperi J; Milgram E; Martin A
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():103-9. PubMed ID: 8396081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flucloxacillin-induced cholestatic liver damage.
    Bengtsson F; Florén CH; Hägerstrand I; Söderström C; Aberg T
    Scand J Infect Dis; 1985; 17(1):125-8. PubMed ID: 3992199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flucloxacillin-associated hepatic injury.
    Koek GH; Stricker BH; Blok AP; Schalm SW; Desmet VJ
    Liver; 1994 Oct; 14(5):225-9. PubMed ID: 7997079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone.
    Köndell PA; Nord CE; Nordenram A
    Int J Oral Surg; 1982 Feb; 11(1):40-3. PubMed ID: 6811456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestatic hepatitis associated with flucloxacillin.
    Derby LE; Jick H; Henry DA; Dean AD
    Med J Aust; 1993 May; 158(9):596-600. PubMed ID: 8479374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.
    McNeil JJ; Grabsch EA; McDonald MM
    Med J Aust; 1999 Mar; 170(6):270-3. PubMed ID: 10212650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis.
    Lanbeck P; Odenholt I; Paulsen O
    Scand J Infect Dis; 2003; 35(6-7):397-400. PubMed ID: 12953952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
    Wing K; Bhaskaran K; Pealing L; Root A; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
    J Antimicrob Chemother; 2017 Sep; 72(9):2636-2646. PubMed ID: 28859440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury.
    Monshi MM; Faulkner L; Gibson A; Jenkins RE; Farrell J; Earnshaw CJ; Alfirevic A; Cederbrant K; Daly AK; French N; Pirmohamed M; Park BK; Naisbitt DJ
    Hepatology; 2013 Feb; 57(2):727-39. PubMed ID: 22987284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.